Project description
New technology to increase the safety and security of pharmaceutical products
Fake medicines pass themselves off as real, authorised medicines, but they are not. They may contain ingredients of low quality or in the wrong doses, or have fake packaging and the wrong ingredients. Under the EU’s Falsified Medicines Directive, all medicines have a unique code that makes it possible to track and verify. But the unique identifier (2D barcode) is on the packaging. There is currently no technical means to ensure the content has not been tampered with. The EU-funded SRAP project will enable true authentication on the product level – not just the package. It will provide fast, reliable and full tracking and tracing along the supply chain without the need to destroy the product during authentication. The SRAP solution can also provide a database-independent authentication via mobile phone.
Objective
The occurrence of cross-border illicit trade and seizures of counterfeit goods by EU-authorities continues to rise year on year. The OECD and the EU’s Intellectual Property Office (EUIPO) estimate that imports of counterfeit and pirated goods are worth nearly half a trillion dollars a year, or around 2.5% of global imports, with US, Italian and French brands the hardest hit. In the EU, the Falsified Medicines Directive (FMD) requires the introduction of a full tracking and tracing system by February 2019. Medicine packs will need to contain a unique identifier (2D barcode) and an anti-tampering device (such as labels), i.e. a technical means to ensure that the content of the package has not been tampered with. At present, there is no technology available on the global market which allows a true authentication of pharmaceutical products themselves, all initiatives so far concentrate on packaging only. SRAP technology overcomes this gap. SRAP is compatible with future FMD regulations; and can provide for fast, reliable and full tracking-and-tracing along the supply chain without the need to destroy product during authentication, while enabling true authentication on the product level - not just the package; and if necessary SRAP solutions provide for a database-independent authentication in the field (via mobile phone) – a very strong set of functionalities that combine to an extremely strong USP. The objectives of feasibility study are as follows – identify 3 potential commercial partners from pharmaceutical industry, define full-scale terms of reference jointly with the 3 partners identified and prepare a full business plan for a new joint venture entity.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences health sciences public health
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs
- engineering and technology electrical engineering, electronic engineering, information engineering information engineering telecommunications mobile phones
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.3.7. - Secure societies - Protecting freedom and security of Europe and its citizens
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-SMEInst-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
6060 SARNEN
Switzerland
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.